Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Summer travel should be catalyst for commercial aero, says Wells Fargo » 17:05
05/12/21
05/12
17:05
05/12/21
17:05
HWM

Howmet Aerospace

$31.89 /

-0.51 (-1.57%)

, TDG

TransDigm

$579.86 /

-19.745 (-3.29%)

, BA

Boeing

$220.78 /

-8.13 (-3.55%)

, GS

Goldman Sachs

$354.46 /

-5.47 (-1.52%)

, LDOS

Leidos

$101.53 /

-3.16 (-3.02%)

, CACI

CACI

$253.96 /

-8.98 (-3.42%)

, RTX

Raytheon Technologies

$82.30 /

-2.04 (-2.42%)

, LMT

Lockheed Martin

$380.24 /

-7.53 (-1.94%)

, LHX

L3Harris Technologies

$211.07 /

-2.255 (-1.06%)

, WWD

Woodward

$118.99 /

-5.86 (-4.69%)

, MANT

ManTech

$83.15 /

-0.44 (-0.53%)

, SAIC

SAIC

$87.46 /

-1.48 (-1.66%)

, NOC

Northrop Grumman

$363.40 /

-5.01 (-1.36%)

, BAH

Booz Allen

$80.77 /

-0.87 (-1.07%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WWD Woodward
$118.99 /

-5.86 (-4.69%)

TDG TransDigm
$579.86 /

-19.745 (-3.29%)

SAIC SAIC
$87.46 /

-1.48 (-1.66%)

RTX Raytheon Technologies
$82.30 /

-2.04 (-2.42%)

NOC Northrop Grumman
$363.40 /

-5.01 (-1.36%)

MANT ManTech
$83.15 /

-0.44 (-0.53%)

LMT Lockheed Martin
$380.24 /

-7.53 (-1.94%)

LHX L3Harris Technologies
$211.07 /

-2.255 (-1.06%)

LDOS Leidos
$101.53 /

-3.16 (-3.02%)

HWM Howmet Aerospace
$31.89 /

-0.51 (-1.57%)

GS Goldman Sachs
$354.46 /

-5.47 (-1.52%)

CACI CACI
$253.96 /

-8.98 (-3.42%)

BAH Booz Allen
$80.77 /

-0.87 (-1.07%)

BA Boeing
$220.78 /

-8.13 (-3.55%)

HWM Howmet Aerospace
$31.89 /

-0.51 (-1.57%)

16:57 Today Wells Fargo
Howmet Aerospace initiated with an Overweight at Wells Fargo
04/07/21 JPMorgan
Howmet Aerospace price target raised to $35 from $32 at JPMorgan
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 KeyBanc
KeyBanc bullish on Howmet Aerospace, initiates with an Overweight
TDG TransDigm
$579.86 /

-19.745 (-3.29%)

09:56 Today
Fly Intel: Top five analyst upgrades
07:45 Today Canaccord
TransDigm price target raised to $670 from $660 at Canaccord
06:57 Today Vertical Research
TransDigm upgraded to Buy on aerospace momenutum at Vertical Research
06:52 Today Vertical Research
TransDigm upgraded to Buy from Hold at Vertical Research
BA Boeing
$220.78 /

-8.13 (-3.55%)

17:04 Today Wells Fargo
Boeing initiated with an Equal Weight at Wells Fargo
05/11/21 Morgan Stanley
Morgan Stanley says Boeing dip a 'particularly attractive buying opportunity'
05/04/21
Fly Intel: Top five analyst upgrades
05/04/21 Bernstein
Bernstein upgrades Boeing to Market Perform on 'less company-specific risk'
GS Goldman Sachs
$354.46 /

-5.47 (-1.52%)

04/23/21 Citi
Goldman Sachs price target raised to $410 from $390 at Citi
04/21/21 Berenberg
Goldman Sachs price target raised to $330 from $270 at Berenberg
04/18/21 BMO Capital
OneMain Holdings downgraded to Market Perform from Outperform at BMO Capital
04/16/21 BMO Capital
Goldman Sachs price target raised to $432 from $409 at BMO Capital
LDOS Leidos
$101.53 /

-3.16 (-3.02%)

17:00 Today Wells Fargo
Leidos initiated with an Overweight at Wells Fargo
04/05/21 Goldman Sachs
Leidos upgraded to Buy from Neutral at Goldman Sachs
03/26/21 Stifel
Stifel downgrades SAIC to Hold after 'materially reset' expectations
03/08/21 Argus
Leidos price target lowered to $100 from $110 at Argus
CACI CACI
$253.96 /

-8.98 (-3.42%)

16:55 Today Wells Fargo
CACI initiated with an Overweight at Wells Fargo
04/26/21 Barclays
CACI price target raised to $300 from $250 at Barclays
02/23/21 William Blair
William Blair reiterates Outperform on Leidos following quarterly results
RTX Raytheon Technologies
$82.30 /

-2.04 (-2.42%)

17:03 Today Wells Fargo
Raytheon Technologies initiated with an Equal Weight at Wells Fargo
05/10/21
Fly Intel: Top five analyst initiations
05/10/21 Redburn
Redburn starts Raytheon Technologies at Buy, sees 28% upside
05/07/21
Fly Intel: Top five analyst initiations
LMT Lockheed Martin
$380.24 /

-7.53 (-1.94%)

17:01 Today Wells Fargo
Lockheed Martin initiated with an Equal Weight at Wells Fargo
04/27/21 Truist
Aerojet Rocketdyne price target lowered to $51 from $56 at Truist
04/09/21 Wolfe Research
Lockheed Martin assumed with a Peer Perform at Wolfe Research
01/27/21 Credit Suisse
Lockheed Martin price target lowered to $334 from $351 at Credit Suisse
LHX L3Harris Technologies
$211.07 /

-2.255 (-1.06%)

16:58 Today Wells Fargo
L3Harris Technologies initiated with an Equal Weight at Wells Fargo
04/27/21
Fly Intel: Top five analyst downgrades
04/27/21 Benchmark
L3Harris Technologies downgraded to Hold from Buy at Benchmark
04/08/21
Fly Intel: Top five analyst downgrades
WWD Woodward
$118.99 /

-5.86 (-4.69%)

05/04/21 Truist
Woodward price target raised to $118 from $108 at Truist
01/11/21 Truist
Woodward upgraded to Hold from Sell at Truist
12/13/20 Goldman Sachs
Woodward initiated with a Neutral at Goldman Sachs
12/04/20 Barclays
Woodward downgraded to Equal Weight from Overweight at Barclays
MANT ManTech
$83.15 /

-0.44 (-0.53%)

17:02 Today Wells Fargo
ManTech initiated with an Equal Weight at Wells Fargo
02/09/21 Alliance Global Partners
ManTech downgraded to Neutral from Buy at Alliance Global Partners
07/30/20 Alliance Global Partners
ManTech upgraded to Buy from Neutral at Alliance Global Partners
SAIC SAIC
$87.46 /

-1.48 (-1.66%)

17:04 Today Wells Fargo
SAIC initiated with an Equal Weight at Wells Fargo
06:36 Today Barclays
SAIC price target lowered to $100 from $107 at Barclays
04/05/21
Fly Intel: Top five analyst downgrades
04/05/21 Goldman Sachs
SAIC downgraded to Neutral from Buy at Goldman Sachs
NOC Northrop Grumman
$363.40 /

-5.01 (-1.36%)

17:03 Today Wells Fargo
Northrop Grumman initiated with an Underweight at Wells Fargo
04/30/21 Susquehanna
Northrop Grumman price target raised to $409 from $350 at Susquehanna
04/09/21 Wolfe Research
Northrop Grumman assumed with an Outperform at Wolfe Research
01/29/21 Credit Suisse
Northrop Grumman price target lowered to $353 from $377 at Credit Suisse
BAH Booz Allen
$80.77 /

-0.87 (-1.07%)

16:53 Today Wells Fargo
Booz Allen initiated with an Overweight at Wells Fargo
06:34 Today Barclays
Booz Allen price target raised to $85 from $78 at Barclays
08/03/20 Truist
Booz Allen downgraded to Hold from Buy at Truist
WWD Woodward
$118.99 /

-5.86 (-4.69%)

TDG TransDigm
$579.86 /

-19.745 (-3.29%)

SAIC SAIC
$87.46 /

-1.48 (-1.66%)

RTX Raytheon Technologies
$82.30 /

-2.04 (-2.42%)

NOC Northrop Grumman
$363.40 /

-5.01 (-1.36%)

MANT ManTech
$83.15 /

-0.44 (-0.53%)

LMT Lockheed Martin
$380.24 /

-7.53 (-1.94%)

LHX L3Harris Technologies
$211.07 /

-2.255 (-1.06%)

LDOS Leidos
$101.53 /

-3.16 (-3.02%)

HWM Howmet Aerospace
$31.89 /

-0.51 (-1.57%)

GS Goldman Sachs
$354.46 /

-5.47 (-1.52%)

CACI CACI
$253.96 /

-8.98 (-3.42%)

BAH Booz Allen
$80.77 /

-0.87 (-1.07%)

BA Boeing
$220.78 /

-8.13 (-3.55%)

WWD Woodward
$118.99 /

-5.86 (-4.69%)

RTX Raytheon Technologies
$82.30 /

-2.04 (-2.42%)

LMT Lockheed Martin
$380.24 /

-7.53 (-1.94%)

LHX L3Harris Technologies
$211.07 /

-2.255 (-1.06%)

LDOS Leidos
$101.53 /

-3.16 (-3.02%)

GS Goldman Sachs
$354.46 /

-5.47 (-1.52%)

BA Boeing
$220.78 /

-8.13 (-3.55%)

WWD Woodward
$118.99 /

-5.86 (-4.69%)

SAIC SAIC
$87.46 /

-1.48 (-1.66%)

RTX Raytheon Technologies
$82.30 /

-2.04 (-2.42%)

NOC Northrop Grumman
$363.40 /

-5.01 (-1.36%)

MANT ManTech
$83.15 /

-0.44 (-0.53%)

LMT Lockheed Martin
$380.24 /

-7.53 (-1.94%)

LDOS Leidos
$101.53 /

-3.16 (-3.02%)

GS Goldman Sachs
$354.46 /

-5.47 (-1.52%)

CACI CACI
$253.96 /

-8.98 (-3.42%)

BA Boeing
$220.78 /

-8.13 (-3.55%)

RTX Raytheon Technologies
$82.30 /

-2.04 (-2.42%)

NOC Northrop Grumman
$363.40 /

-5.01 (-1.36%)

LMT Lockheed Martin
$380.24 /

-7.53 (-1.94%)

GS Goldman Sachs
$354.46 /

-5.47 (-1.52%)

BA Boeing
$220.78 /

-8.13 (-3.55%)

Initiation
CACI initiated with an Overweight at Wells Fargo » 16:55
05/12/21
05/12
16:55
05/12/21
16:55
CACI

CACI

$253.96 /

-8.98 (-3.42%)

Wells Fargo analyst…

Wells Fargo analyst Matthew Akers initiated coverage of CACI with an Overweight rating and $311 price target in a broader sector initiation on Aerospace, Defense, and Government Services.

ShowHide Related Items >><<
CACI CACI
$253.96 /

-8.98 (-3.42%)

CACI CACI
$253.96 /

-8.98 (-3.42%)

04/26/21 Barclays
CACI price target raised to $300 from $250 at Barclays
03/26/21 Stifel
Stifel downgrades SAIC to Hold after 'materially reset' expectations
02/23/21 William Blair
William Blair reiterates Outperform on Leidos following quarterly results
01/29/21 Truist
CACI price target raised to $290 from $275 at Truist
CACI CACI
$253.96 /

-8.98 (-3.42%)

CACI CACI
$253.96 /

-8.98 (-3.42%)

Hot Stocks
Evolus' Jeuveau on track for $100M annual net revenue run rate in Q2 » 16:25
05/12/21
05/12
16:25
05/12/21
16:25
EOLS

Evolus

$8.40 /

-0.34 (-3.89%)

"We believe Jeuveau…

"We believe Jeuveau is on track to achieve an annualized net revenue run rate of $100M in the second quarter of 2021," said Evolus CEO David Moatazedi.

ShowHide Related Items >><<
EOLS Evolus
$8.40 /

-0.34 (-3.89%)

EOLS Evolus
$8.40 /

-0.34 (-3.89%)

05/06/21 Mizuho
Evolus upgraded to Buy from Neutral at Mizuho
04/08/21 H.C. Wainwright
Evolus price target raised to $22 from $20 at H.C. Wainwright
03/30/21 Mizuho
Evolus price target raised to $15 from $9 at Mizuho
03/24/21 H.C. Wainwright
Evolus price target raised to $20 from $18 at H.C. Wainwright
EOLS Evolus
$8.40 /

-0.34 (-3.89%)

  • 22
    Apr
EOLS Evolus
$8.40 /

-0.34 (-3.89%)

EOLS Evolus
$8.40 /

-0.34 (-3.89%)

EOLS Evolus
$8.40 /

-0.34 (-3.89%)

Earnings
Evolus reports Q1 diluted EPS 16c, may not compare to consensus (43c) » 16:24
05/12/21
05/12
16:24
05/12/21
16:24
EOLS

Evolus

$8.40 /

-0.34 (-3.89%)

Reports Q1 revenue…

Reports Q1 revenue $12.2M, consensus $11.67M.

ShowHide Related Items >><<
EOLS Evolus
$8.40 /

-0.34 (-3.89%)

EOLS Evolus
$8.40 /

-0.34 (-3.89%)

05/06/21 Mizuho
Evolus upgraded to Buy from Neutral at Mizuho
04/08/21 H.C. Wainwright
Evolus price target raised to $22 from $20 at H.C. Wainwright
03/30/21 Mizuho
Evolus price target raised to $15 from $9 at Mizuho
03/24/21 H.C. Wainwright
Evolus price target raised to $20 from $18 at H.C. Wainwright
EOLS Evolus
$8.40 /

-0.34 (-3.89%)

  • 22
    Apr
EOLS Evolus
$8.40 /

-0.34 (-3.89%)

EOLS Evolus
$8.40 /

-0.34 (-3.89%)

EOLS Evolus
$8.40 /

-0.34 (-3.89%)

Hot Stocks
North American rail traffic rose 23.2% in week ended May 8, AAR says » 13:44
05/12/21
05/12
13:44
05/12/21
13:44
CNI

Canadian National

$111.11 /

-1.34 (-1.19%)

, CP

Canadian Pacific

$392.51 /

-2.78 (-0.70%)

, CSX

CSX

$99.89 /

-1.64 (-1.62%)

, KSU

Kansas City Southern

$306.69 /

-1.51 (-0.49%)

, NSC

Norfolk Southern

$282.61 /

-3.79 (-1.32%)

, UNP

Union Pacific

$222.47 /

-4.12 (-1.82%)

, GWR

Genesee & Wyoming

$111.91 /

+ (+0.00%)

The Association of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UNP Union Pacific
$222.47 /

-4.12 (-1.82%)

NSC Norfolk Southern
$282.61 /

-3.79 (-1.32%)

KSU Kansas City Southern
$306.69 /

-1.51 (-0.49%)

GWR Genesee & Wyoming
$111.91 /

+ (+0.00%)

CSX CSX
$99.89 /

-1.64 (-1.62%)

CP Canadian Pacific
$392.51 /

-2.78 (-0.70%)

CNI Canadian National
$111.11 /

-1.34 (-1.19%)

CNI Canadian National
$111.11 /

-1.34 (-1.19%)

04/27/21 CIBC
Canadian National price target lowered to C$146 from C$148 at CIBC
04/27/21 Wells Fargo
Canadian National price target raised to $120 from $113 at Wells Fargo
04/26/21 Susquehanna
Canadian Pacific will have to raise bid to win KSU war, says Susquehanna
04/22/21 Credit Suisse
Canadian Pacific not planning to preemptively raise bid, says Credit Suisse
CP Canadian Pacific
$392.51 /

-2.78 (-0.70%)

04/26/21 Deutsche Bank
Canadian Pacific price target raised to $405 from $368 at Deutsche Bank
04/23/21 Desjardins
Canadian Pacific price target raised to C$529 from C$525 at Desjardins
04/22/21 National Bank
Canadian Pacific price target lowered to C$511 from C$515 at National Bank
CSX CSX
$99.89 /

-1.64 (-1.62%)

04/21/21 Deutsche Bank
CSX price target raised to $113 from $105 at Deutsche Bank
04/21/21 RBC Capital
CSX price target raised to $108 from $100 at RBC Capital
04/21/21 BMO Capital
CSX upgraded to Outperform from Market Perform at BMO Capital
03/26/21 Vertical Research
CSX reinstated with a Hold at Vertical Research
KSU Kansas City Southern
$306.69 /

-1.51 (-0.49%)

04/26/21 Deutsche Bank
Kansas City Southern price target raised to $300 from $212 at Deutsche Bank
04/22/21 Susquehanna
Canadian Pacific price target raised to $403 from $402 at Susquehanna
NSC Norfolk Southern
$282.61 /

-3.79 (-1.32%)

05/04/21 Argus
Norfolk Southern price target raised to $310 from $275 at Argus
04/29/21 BMO Capital
Norfolk Southern price target raised to $285 from $250 at BMO Capital
04/29/21 Barclays
Norfolk Southern price target raised to $300 from $272 at Barclays
04/29/21 Benchmark
Norfolk Southern price target raised to $315 from $295 at Benchmark
UNP Union Pacific
$222.47 /

-4.12 (-1.82%)

04/26/21 Deutsche Bank
Union Pacific price target raised to $252 from $239 at Deutsche Bank
04/23/21 RBC Capital
Union Pacific price target raised to $244 from $232 at RBC Capital
04/23/21 BMO Capital
Union Pacific price target raised to $240 from $230 at BMO Capital
04/23/21 Morgan Stanley
Union Pacific price target raised to $190 from $180 at Morgan Stanley
GWR Genesee & Wyoming
$111.91 /

+ (+0.00%)

UNP Union Pacific
$222.47 /

-4.12 (-1.82%)

NSC Norfolk Southern
$282.61 /

-3.79 (-1.32%)

KSU Kansas City Southern
$306.69 /

-1.51 (-0.49%)

CSX CSX
$99.89 /

-1.64 (-1.62%)

CP Canadian Pacific
$392.51 /

-2.78 (-0.70%)

CNI Canadian National
$111.11 /

-1.34 (-1.19%)

UNP Union Pacific
$222.47 /

-4.12 (-1.82%)

NSC Norfolk Southern
$282.61 /

-3.79 (-1.32%)

CP Canadian Pacific
$392.51 /

-2.78 (-0.70%)

CNI Canadian National
$111.11 /

-1.34 (-1.19%)

CSX CSX
$99.89 /

-1.64 (-1.62%)

CP Canadian Pacific
$392.51 /

-2.78 (-0.70%)

CNI Canadian National
$111.11 /

-1.34 (-1.19%)

UNP Union Pacific
$222.47 /

-4.12 (-1.82%)

KSU Kansas City Southern
$306.69 /

-1.51 (-0.49%)

CSX CSX
$99.89 /

-1.64 (-1.62%)

Options
Kinder Morgan call volume above normal and directionally bullish » 11:45
05/12/21
05/12
11:45
05/12/21
11:45
KMI

Kinder Morgan

$18.45 /

+0.475 (+2.64%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KMI Kinder Morgan
$18.45 /

+0.475 (+2.64%)

KMI Kinder Morgan
$18.45 /

+0.475 (+2.64%)

04/27/21 Citi
Kinder Morgan price target raised to $17 from $15.50 at Citi
04/22/21 RBC Capital
Kinder Morgan price target raised to $17 from $16 at RBC Capital
04/22/21 Mizuho
Kinder Morgan price target raised to $20 from $19 at Mizuho
03/09/21
Fly Intel: Top five analyst downgrades
KMI Kinder Morgan
$18.45 /

+0.475 (+2.64%)

KMI Kinder Morgan
$18.45 /

+0.475 (+2.64%)

KMI Kinder Morgan
$18.45 /

+0.475 (+2.64%)

KMI Kinder Morgan
$18.45 /

+0.475 (+2.64%)

Hot Stocks
Ackman says Chipotle can offset wage increases with price increases » 10:13
05/12/21
05/12
10:13
05/12/21
10:13
CMG

Chipotle

$1,368.32 /

-24.31 (-1.75%)

Pershing Square Capital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMG Chipotle
$1,368.32 /

-24.31 (-1.75%)

CMG Chipotle
$1,368.32 /

-24.31 (-1.75%)

05/10/21 Stephens
Chipotle will quickly raise prices to offset wage hike, says Stephens
04/27/21 RBC Capital
Chipotle price target raised to $1,750 from $1,730 at RBC Capital
04/23/21 Deutsche Bank
Chipotle price target raised to $1,495 from $1,462 at Deutsche Bank
04/22/21 Evercore ISI
Chipotle price target raised to $1,725 from $1,650 at Evercore ISI
CMG Chipotle
$1,368.32 /

-24.31 (-1.75%)

CMG Chipotle
$1,368.32 /

-24.31 (-1.75%)

CMG Chipotle
$1,368.32 /

-24.31 (-1.75%)

CMG Chipotle
$1,368.32 /

-24.31 (-1.75%)

Hot Stocks
NeuBase Therapeutics appoints Gerald McDougall to board of directors » 09:09
05/12/21
05/12
09:09
05/12/21
09:09
NBSE

NeuBase Therapeutics

$4.91 /

+0.01 (+0.20%)

NeuBase Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NBSE NeuBase Therapeutics
$4.91 /

+0.01 (+0.20%)

NBSE NeuBase Therapeutics
$4.91 /

+0.01 (+0.20%)

02/12/21 H.C. Wainwright
NeuBase Therapeutics price target raised to $18 from $15 at H.C. Wainwright
06/16/20 RBC Capital
NeuBase Therapeutics initiated with an Outperform at RBC Capital
NBSE NeuBase Therapeutics
$4.91 /

+0.01 (+0.20%)

  • 22
    Apr
NBSE NeuBase Therapeutics
$4.91 /

+0.01 (+0.20%)

Hot Stocks
Evolus announces two published studies on safety, efficacy of Jeuveau » 09:05
05/12/21
05/12
09:05
05/12/21
09:05
EOLS

Evolus

$8.74 /

-0.13 (-1.47%)

Evolus announced two…

Evolus announced two newly published peer review studies in Aesthetic Surgery Journal that provide supportive evidence of the safety and efficacy of repeat doses of prabotulinumtoxinA to decrease the appearance of glabellar lines, also known as frown lines between the eyes. The two Phase II studies, conducted to support the registration and regulatory approval of Jeuveau in the United States, Canada and Europe, demonstrate that prolonged use of Jeuveau is safe and effective with repeat treatments. The studies also reveal that the patented Hi-Pure manufacturing technology used to make Jeuveau is not associated with antibody formation or neutralizing antibody formation. Both studies were long-term, open-label, phase II studies designed to investigate the safety of repeat doses of 20 U prabotulinumtoxinA for the treatment of glabellar lines. The complementary studies primarily differed in the number of patients and in the product formulation process employed. In both studies, among study completers, there was no evidence of shortening retreatment periods that might suggest immunogenicity and/or the development of resistance; in fact, the opposite was observed, with a trend towards longer retreatment periods. This is important because, when treating patients with a biological agent, a shortening time interval between treatments may be suggestive of increasing resistance or antibody development. In addition, the percentage of patients who experienced an adverse event after treatment decreased with repeat exposure. The most reported AE was headache. There were no serious adverse reactions related to the drug. Jeuveau is marketed in the United States by Evolus. The product is marketed by a partner in Canada as Nuceiva with European launch planned for early 2022.

ShowHide Related Items >><<
EOLS Evolus
$8.74 /

-0.13 (-1.47%)

EOLS Evolus
$8.74 /

-0.13 (-1.47%)

05/06/21 Mizuho
Evolus upgraded to Buy from Neutral at Mizuho
04/08/21 H.C. Wainwright
Evolus price target raised to $22 from $20 at H.C. Wainwright
03/30/21 Mizuho
Evolus price target raised to $15 from $9 at Mizuho
03/24/21 H.C. Wainwright
Evolus price target raised to $20 from $18 at H.C. Wainwright
EOLS Evolus
$8.74 /

-0.13 (-1.47%)

  • 22
    Apr
EOLS Evolus
$8.74 /

-0.13 (-1.47%)

EOLS Evolus
$8.74 /

-0.13 (-1.47%)

EOLS Evolus
$8.74 /

-0.13 (-1.47%)

Conference/Events
UFP Industries management to meet virtually with Wedbush » 04:55
05/12/21
05/12
04:55
05/12/21
04:55
UFPI

UFP Industries

$84.24 /

-4.16 (-4.71%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UFPI UFP Industries
$84.24 /

-4.16 (-4.71%)

UFPI UFP Industries
$84.24 /

-4.16 (-4.71%)

04/22/21 Wedbush
UFP Industries price target raised to $85 from $75 at Wedbush
04/22/21 Benchmark
UFP Industries price target raised to $97 from $80 at Benchmark
04/15/21 Wedbush
UFP Industries price target raised to $75 from $65 at Wedbush
03/22/21 DA Davidson
UFP Industries price target raised to $80 from $75 at DA Davidson
UFPI UFP Industries
$84.24 /

-4.16 (-4.71%)

UFPI UFP Industries
$84.24 /

-4.16 (-4.71%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.